Close Menu

NEW YORK ─ The US Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) has awarded a $5.65 million contract to LightDeck Diagnostics to develop a rapid, point-of-care antigen test that detects SARS-CoV-2 in less than six minutes, the firm said on Monday.

The LightDeck COVID-19 Antigen Test leverages a simple test procedure and waveguide technology along with cost-effective manufacturing that would lead to an accurate, scalable test, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.